IL17 Cancer Research Results
IL17, Interleukin-17: Click to Expand ⟱
| Source: |
| Type: |
Also known as IL-17A.
Interleukin-17A is a protein that in humans is encoded by the IL17A gene.
Higher levels of serum IL-17 are associated with poor prognosis for a variety of solid tumors in cancer patients.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
Inflam↓, *NO↓, *IL10↑, *ICAM-1↓, *VCAM-1↓, *E-sel↓, *NF-kB↓, *IKKα↓, *COX2↓, *PGE2↓, *IL1β↓, *IL6↓, *IL8↓, *IL12↓, *TNF-α↑, *HO-1↑, *IL10↑, *IL2↓, *IL17↓, *IFN-γ↓, *SOD↑, *GPx↑, *GSR↑, *MDA↓, *MAPK↓,
*ROS↓, *Inflam↓, *IL1β↓, *IL6↓, *IL8↓, *IL17↓, *CXCR4↓, *COX2↓, *TLR4↓, *NO↓, *MDA↓, *XO↓,
*Imm↑, *GastroP↑, *Inflam↓, AntiCan↑, *AntiBio↑, *hepatoP↑, *CD4+↑, *IFN-γ↓, *IL17↓, *GutMicro↑, *antiOx↑, *AST↓, *ALAT↓, *HDL↑, *LDL↓, *ROS↓, *lipid-P↓, *Inflam↓, *Aβ↓,
AntiCan↑, *AntiDiabetic↑, *neuroP↑, *Inflam↓, *antiOx↑, *BioAv↓, *BioAv↑, *SOD↑, *GPx↑, *GSH↑, *NRF2↑, *ROS↓, *lipid-P↓, *Cyt‑c↓, *BAX↓, *Bcl-2↓, *iNOS↓, *NO↓, *IL6↓, *IL10↓, *IL17↓, *IFN-γ↓, *NF-kB↓, *LC3II↓, *Akt↓, *Beclin-1↓, *AMPK↓, *TNF-α↓, *PGE2↓, *Apoptosis↓, *Casp3↓, *Casp9↓, *P53↓, *P21↓, *NAD↓, *ATP↓, *CHOP/DDIT3↓, *GADD34↓, *ATF4↓, tumCV↓, Apoptosis↑, TumCG↓, TumCI↓, TumMeta↓, CSCs↓, NOTCH1↓, STAT3↓, eff↑, miR-34a↓, *neuroP↑, *BDNF↓, *hepatoP↑, *ALAT↓, *AST↓, TG/TAG↓, ROS↑, Slug↓, EMT↓, Glycolysis↓, ChemoSen↑, P-gp↓, Ki-67↓, PCNA↓, ER Stress↑, TRIB3↑, NF-kB↑, TumMeta↑, *Imm↓, *toxicity↝,
*Inflam↓, *IL1↓, *IL6↓, IL17↓, *TNF-α↓,
*other↓, *CD25+↓, *IFN-γ↓, *IL2↓, *IL4↓, *IL17↓, *CD69↓, *CTLA-4↓, *p‑ERK↓, *IKKα↓,
Dose↝, Casp3↑, MMP9↓, COX2↓, NF-kB↓, PI3K↓, Akt↓, ERK↓, Inflam↓, TNF-α↓, IL6↓, IL17↓, IL22↓, IL23↓,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 1, Casp3↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PCNA↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, EMT↓, 1, ERK↓, 1, miR-34a↓, 1, NOTCH1↓, 1, PI3K↓, 1, STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ki-67↓, 1, MMP9↓, 1, Slug↓, 1, TRIB3↑, 1, TumCI↓, 1, TumMeta↓, 1, TumMeta↑, 1,
Barriers & Transport(tgid=15) ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, IL17↓, 2, IL22↓, 1, IL23↓, 1, IL6↓, 1, Inflam↓, 2, NF-kB↓, 1, NF-kB↑, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1, Ki-67↓, 1, TG/TAG↓, 1, TRIB3↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2,
Total Targets: 41
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, GPx↑, 2, GSH↑, 1, GSR↑, 1, HDL↑, 1, HO-1↑, 1, lipid-P↓, 2, MDA↓, 2, NRF2↑, 1, ROS↓, 3, SOD↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 2, AMPK↓, 1, LDL↓, 1, NAD↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↓, 1, BAX↓, 1, Bcl-2↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, GADD34↓, 1, iNOS↓, 1, MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1↓, 1, LC3II↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑ERK↓, 1,
Migration(tgid=13) ⓘ
E-sel↓, 1, VCAM-1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↓, 1, NO↓, 3,
Barriers & Transport(tgid=15) ⓘ
GastroP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD25+↓, 1, CD4+↑, 1, CD69↓, 1, COX2↓, 2, CTLA-4↓, 1, CXCR4↓, 1, ICAM-1↓, 1, IFN-γ↓, 4, IKKα↓, 2, IL1↓, 1, IL10↓, 1, IL10↑, 2, IL12↓, 1, IL17↓, 5, IL1β↓, 2, IL2↓, 2, IL4↓, 1, IL6↓, 4, IL8↓, 2, Imm↓, 1, Imm↑, 1, Inflam↓, 5, NF-kB↓, 2, PGE2↓, 2, TLR4↓, 1, TNF-α↓, 2, TNF-α↑, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, XO↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 2, AST↓, 2, GutMicro↑, 1, IL6↓, 4,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, hepatoP↑, 2, neuroP↑, 2, toxicity↝, 1,
Total Targets: 79
Scientific Paper Hit Count for: IL17, Interleukin-17
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:540 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page